BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Company profile
Ticker
CNVCF
Exchange
Website
CEO
Mr. Ilan Sobel
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HIVE Blockchain Technologies Ltd.
SEC CIK
CNVCF stock data
Latest filings (excl ownership)
6-K
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
12 Nov 24
CERT
Certification of approval for exchange listing
8 Nov 24
CERT
Certification of approval for exchange listing
8 Nov 24
6-K
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
8 Nov 24
6-K
Material Change Report
28 Oct 24
6-K
BioHarvest Sciences Appoints Bar Dichter as CFO
28 Oct 24
8-A12B
Registration of securities on exchange
28 Oct 24
6-K
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
23 Oct 24
6-K
Current report (foreign)
16 Oct 24
6-K
Material Change Report
20 Sep 24
Latest ownership filings
No filings
Press releases
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
12 Nov 24
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
7 Nov 24
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results
23 Oct 24
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024
16 Oct 24
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board
20 Sep 24